Publications by authors named "Erasmus Bachus"

Claim this Profile
I
Impact of cerebral oxygen saturation on mortality and rehospitalisation in patients with heart failure and the role of physical activity as a modifying factor: the HARVEST-Malmö Study.
Amir Zaghi, Amra Jujic, Haris Zilic, Anna Dieden, Erasmus Bachus

Heart· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic biomarkers and pathway analysis for progression to heart failure in three epidemiological representative cohorts.
Anna Dieden, Nicolas Girerd, Filip Ottosson, John Molvin, Manan Pareek, Erasmus Bachus

Eur J Heart Fail· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EuroQol 5-Dimension Questionnaire in Heart Failure With Reduced, Mildly Reduced, and Preserved Ejection Fraction: A Patient-Level Analysis of DAPA-HF and DELIVER.
Mingming Yang, Toru Kondo, Atefeh Talebi, Pardeep S Jhund, Kieran F Docherty, Erasmus Bachus

JACC Heart Fail· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dapagliflozin and Timing of Prior Heart Failure Hospitalization: A Patient-Level Meta-Analysis of DAPA-HF and DELIVER.
Jawad H Butt, Pardeep S Jhund, Kieran F Docherty, Brian L Claggett, Muthiah Vaduganathan, Erasmus Bachus

JACC Heart Fail· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of dapagliflozin according to QRS duration across the spectrum of left ventricular ejection fraction: An analysis of DAPA-HF and DELIVER.
Amr Abdin, Toru Kondo, Michael Böhm, Pardeep S Jhund, Brian L Claggett, Erasmus Bachus

Eur J Heart Fail· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dapagliflozin and quality of life measured using the EuroQol 5-dimension questionnaire in patients with heart failure with reduced and mildly reduced/preserved ejection fraction.
Mingming Yang, Toru Kondo, Atefeh Talebi, Pardeep S Jhund, Kieran F Docherty, Erasmus Bachus

Eur J Heart Fail· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Models for Mortality and Morbidity in Heart Failure With Preserved Ejection Fraction.
Kirsty McDowell, Toru Kondo, Atefeh Talebi, Ken Teh, Erasmus Bachus

JAMA Cardiol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of dapagliflozin for patients with heart failure across the spectrum of ejection fraction: A pooled analysis of DAPA-HF and DELIVER data.
Jason A Davis, David Booth, Phil McEwan, Scott D Solomon, John J V McMurray, Erasmus Bachus

Eur J Heart Fail· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Dapagliflozin According to Heart Rate: A Patient-Level Pooled Analysis of DAPA-HF and DELIVER.
Toru Kondo, Jawad H Butt, James P Curtain, Pardeep S Jhund, Kieran F Docherty, Erasmus Bachus

Circ Heart Fail· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heart failure, chronic obstructive pulmonary disease and efficacy and safety of dapagliflozin in heart failure with mildly reduced or preserved ejection fraction: Insights from DELIVER.
Jawad H Butt, Henri Lu, Toru Kondo, Erasmus Bachus, Rudolf A de Boer

Eur J Heart Fail· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Galectin-4 is associated with diabetes and obesity in a heart failure population.
Anna Dieden, Petri Gudmundsson, Johan Korduner, John Molvin, Amir Zaghi, Erasmus Bachus

Sci Rep· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Dapagliflozin According to Geographic Location of Patients With Heart Failure.
Toru Kondo, Xiaowen Wang, Mingming Yang, Pardeep S Jhund, Brian L Claggett, Erasmus Bachus

J Am Coll Cardiol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cost-effectiveness of dapagliflozin in heart failure with preserved or mildly reduced ejection fraction: A European health-economic analysis of the DELIVER trial.
David Booth, Jason A Davis, Phil McEwan, Scott D Solomon, John J V McMurray, Erasmus Bachus

Eur J Heart Fail· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dapagliflozin for heart failure according to body mass index: the DELIVER trial.
Carly Adamson, Toru Kondo, Pardeep S Jhund, Rudolf A de Boer, Jose Walter Cabrera Honorio, Erasmus Bachus

Eur Heart J· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial.
Jawad H Butt, Pardeep S Jhund, Jan Belohlávek, Rudolf A de Boer, Chern-En Chiang, Erasmus Bachus

Circulation· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of myocardial fibrosis biomarkers in a heart failure population with atrial fibrillation-The HARVEST-Malmö study.
Zainu Nezami, Hannes Holm, Marcus Ohlsson, John Molvin, Johan Korduner, Erasmus Bachus

Front Cardiovasc Med· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.
Scott D Solomon, John J V McMurray, Brian Claggett, Rudolf A de Boer, David DeMets, Erasmus Bachus

N Engl J Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Galectin-4 levels in hospitalized versus non-hospitalized subjects with obesity: the Malmö Preventive Project.
Johan Korduner, Hannes Holm, Amra Jujic, Olle Melander, Manan Pareek, Erasmus Bachus

Cardiovasc Diabetol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physical Inactivity Is Associated With Post-discharge Mortality and Re-hospitalization Risk Among Swedish Heart Failure Patients-The HARVEST-Malmö Study.
Amir Zaghi, Hannes Holm, Johan Korduner, Anna Dieden, John Molvin, Erasmus Bachus

Front Cardiovasc Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Shrunken pore syndrome is associated with poor prognosis and lower quality of life in heart failure patients: the HARVEST-Malmö study.
Liana Xhakollari, Anders Grubb, Amra Jujic, Erasmus Bachus, Peter M Nilsson

ESC Heart Fail· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteins linked to atherosclerosis and cell proliferation are associated with the shrunken pore syndrome in heart failure patients: Shrunken pore syndrome and proteomic associations.
Liana Xhakollari, Amra Jujic, John Molvin, Peter Nilsson, Hannes Holm, Erasmus Bachus

Proteomics Clin Appl· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impaired cerebral oxygenation in heart failure patients at rest and during head-up tilt testing.
Isabella Kharraziha, Hannes Holm, Martin Magnusson, Per Wollmer, John Molvin, Erasmus Bachus

ESC Heart Fail· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognitive test results are associated with mortality and rehospitalization in heart failure: Swedish prospective cohort study.
Hannes Holm, Erasmus Bachus, Amra Jujic, Erik D Nilsson, Benjamin Wadström

ESC Heart Fail· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased pulmonary blood volume variation in patients with heart failure compared to healthy controls: a noninvasive, quantitative measure of heart failure.
Mariam Al-Mashat, Jonas Jögi, Marcus Carlsson, Rasmus Borgquist, Ellen Ostenfeld, Erasmus Bachus

J Appl Physiol (1985)· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebral Oximetry in Syncope and Syndromes of Orthostatic Intolerance.
Isabella Kharraziha, Hannes Holm, Erasmus Bachus, Fabrizio Ricci, Richard Sutton

Front Cardiovasc Med· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis